文献速递生殖医学

植入前非整倍体遗传学检测中混沌型囊胚:发生率、特征及再活检结果

Chaotic blastocysts in preimplantation genetic testing for aneuploidy: prevalence, characterization, and re-biopsy results.
PubMed 文献 · Fertil Steril · 2025-05-07

该回顾性研究分析了2017年11月至2023年12月间1,442个PGT-A周期中的5,801枚囊胚,其中混沌型囊胚发生率为4.3%(251/5,801)。93枚捐赠的混沌型囊胚解冻后存活率为74.2%(69),再活检结果显示24.6%(17)为整倍体,且不同亚型结局差异显著;作者认为再活检可能识别具有良好生殖潜能的胚胎,尤其是 mosaic chaotic 亚型,而 pure 和 mixed 混沌型囊胚再检测持续显示非整倍体。

要点

  • 混沌型囊胚发生率为4.3%(251/5,801),其中pure占13.5%、mixed占53.0%、mosaic占33.5%。
  • 93枚捐赠混沌型囊胚解冻存活率为74.2%(69),再活检后24.6%(17)为整倍体。
  • mosaic chaotic亚型中54.8%(17)再分类为整倍体,而pure和mixed亚型非整倍体一致率为100%。

核心结论

  • 再活检可能识别具有良好生殖潜能的胚胎,尤其是最初分类为mosaic chaotic的胚胎。
  • pure和mixed混沌型囊胚再检测持续显示非整倍体,提示这些亚型再活检获益有限。

研究设计与样本

  • 回顾性研究,纳入2017年11月至2023年12月间1,442个PGT-A周期。
  • 样本为来自22家体外受精诊所的5,801枚囊胚,其中93枚混沌型囊胚捐赠用于再活检。
  • 混沌型胚胎分类为pure(≥5个均匀非整倍体)、mixed(≥5个均匀非整倍体与中间拷贝数染色体组合)和mosaic(≥5个中间拷贝数染色体)。
  • 暴露因素为使用下一代测序对混沌型囊胚进行再活检和再分析。

主要发现

  • 混沌型胚胎发生率为4.3%(251/5,801):pure 13.5%(34)、mixed 53.0%(133)、mosaic 33.5%(84)。
  • 93枚捐赠混沌型胚胎解冻后存活率为74.2%(69)。
  • 存活胚胎再活检PGT-A结果:整倍体24.6%(17)、混沌型37.7%(26)、非混沌非整倍体26.1%(18)、嵌合体7.2%(5)、无信息4.4%(3)。
  • pure混沌型(n=11)中72.7%(8)与初始活检结果完全相同,27.3%(3)再分类为非混沌非整倍体。
  • mixed混沌型(n=24)中54.2%(13)保留mixed混沌型分类,45.8%(11)再分类为非整倍体非混沌型;再分类胚胎与初始活检至少有一个共同非整倍体。

临床怎么用

  • 作者认为再活检可能识别具有良好生殖潜能的胚胎,尤其是最初分类为mosaic chaotic的胚胎。
  • 作者认为pure和mixed混沌型囊胚再检测持续显示非整倍体,提示这些亚型再活检获益有限。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the reproductive potential of blastocysts designated as chaotic by preimplantation genetic testing for aneuploidy (PGT-A) through re-biopsy and re-analysis. DESIGN: Retrospective study of 1,442 PGT-A cycles from November 2017 to December 2023. SUBJECTS: Five thousand eight hundred one blastocysts from 22 in vitro fertilization clinics, including 93 chaotic blastocysts donated for re-biopsy. Chaotic embryos were classified as pure (≥5 uniform aneuploidies), mixed (combination of ≥5 uniform aneuploidies and intermediate copy number chromosomes), and mosaic (≥5 intermediate copy number chromosomes). EXPOSURE: Re-biopsy and re-analysis of chaotic blastocysts using next-generation sequencing. MAIN OUTCOME MEASURES: Prevalence of chaotic embryos, survival rate after thawing, and concordance rate between initial and re-biopsy PGT-A results. RESULTS: The prevalence of chaotic embryos was 4.3% (251/5,801): 13.5% (34) pure, 53.0% (133) mixed, and 33.5% (84) mosaic. After thawing 93 donated chaotic embryos, the survival rate was 74.2% (69). Surviving embryos underwent re-biopsy, yielding the following PGT-A results: 24.6% (17) euploid, 37.7% (26) chaotic, 26.1% (18) aneuploid non-chaotic, 7.2% (5) mosaic, and 4.4% (3) non-informative. Outcomes varied substantially among sub-categories of chaotic embryos. In the pure chaotic category (n = 11), 72.7% (8) yielded results identical to the initial biopsy, whereas 27.3% (3) were re-classified as aneuploid non-chaotic. Within the mixed chaotic category (n = 24), 54.2% (13) retained their mixed chaotic classification, whereas 45.8% (11) were re-classified as aneuploidy non-chaotic. Embryos re-classified into the aforementioned categories had at least one aneuploidy in common with the initial biopsy. Mosaic chaotic category (n = 31) showed the most diverse outcomes: 54.8% (17) were re-classified as euploid, 16.1% (5) remained mosaic chaotic, 16.1% (5) were re-classified as mosaic non-chaotic, and 12.9% (4) as aneuploid non-chaotic. Concordance with the initial biopsy in terms of aneuploid result was 100% in the pure and mixed chaotic categories. However, over half of embryos initially categorized as mosaic chaotic were, in fact, euploid. CONCLUSION: Re-biopsy can potentially identify embryos with favorable reproductive potential, particularly those initially classified as mosaic chaotic. However, pure and mixed chaotic blastocysts consistently show aneuploidy on re-testing, suggesting limited benefit from re-biopsy for these categories.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Calull A, Victores-Monroy A, González-Ortega C, et al. Chaotic blastocysts in preimplantation genetic testing for aneuploidy: prevalence, characterization, and re-biopsy results. Fertil Steril. 2025. PMID: 40332063. doi:10.1016/j.fertnstert.2025.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。